TECTONIC THERAPEUTIC, INC. Common Stock, Capital Shares Reserved for Future Issuance
TECTONIC THERAPEUTIC, INC. (TECX) had Common Stock, Capital Shares Reserved for Future Issuance of 4.49 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 4.49M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 4.51M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 3.43M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 3.46M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 4.49M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 4.51M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 3.43M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 3.46M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 3.46M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 3.53M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 2.78M shares 10-K · filed 2026-02-26 | |
| 2024-03-31 | 18.77M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 6.21M shares 10-K · filed 2025-03-20 | 18.94M shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 18.61M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 18.86M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 19.07M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 19.26M shares 10-K · filed 2024-03-14 | |
| 2022-09-30 | 19.47M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 19.55M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 15.92M shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 13.81M shares 10-K · filed 2023-03-23 | |
| 2021-09-30 | 14.06M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 14.12M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 14.15M shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 12.27M shares 10-K · filed 2022-03-17 | |
| 2020-09-30 | 10.81M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 10.87M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 7.61M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 6.04M shares 10-K · filed 2021-03-18 | |
| 2019-09-30 | 4.14M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 3.95M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 4.10M shares 10-Q · filed 2019-05-13 | |
| 2018-12-31 | 2.93M shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 2.81M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 2.84M shares 10-Q · filed 2018-08-09 | |
| 2017-12-31 | 9.87M shares 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |